Angela D Trobaugh-Lotrario

Summary

Affiliation: Sacred Heart Medical Center
Country: USA

Publications

  1. ncbi Small cell undifferentiated variant of hepatoblastoma: adverse clinical and molecular features similar to rhabdoid tumors
    Angela D Trobaugh-Lotrario
    Department of Hematology Oncology, Sacred Heart Children s Hospital, Spokane, Washington 99204, USA
    Pediatr Blood Cancer 52:328-34. 2009
  2. ncbi Chemotherapeutic approaches for newly diagnosed hepatoblastoma: past, present, and future strategies
    Angela D Trobaugh-Lotrario
    Department of Pediatric Hematology Oncology, Sacred Heart Children s Hospital, Spokane, Washington 99204, USA
    Pediatr Blood Cancer 59:809-12. 2012
  3. ncbi Relapsed hepatoblastoma
    Angela D Trobaugh-Lotrario
    Department of Pediatric Hematology Oncology, Sacred Heart Children s Hospital, Spokane, Washington 99204, USA
    Pediatr Blood Cancer 59:813-7. 2012
  4. ncbi Rhabdoid tumors of the liver: rare, aggressive, and poorly responsive to standard cytotoxic chemotherapy
    Angela D Trobaugh-Lotrario
    Sacred Heart Children s Hospital, Spokane, WA, USA
    Pediatr Blood Cancer 57:423-8. 2011

Detail Information

Publications4

  1. ncbi Small cell undifferentiated variant of hepatoblastoma: adverse clinical and molecular features similar to rhabdoid tumors
    Angela D Trobaugh-Lotrario
    Department of Hematology Oncology, Sacred Heart Children s Hospital, Spokane, Washington 99204, USA
    Pediatr Blood Cancer 52:328-34. 2009
    ..Small cell undifferentiated (SCU) histology in patients with stage I hepatoblastoma (HB) predicts an increased risk of relapse. We sought to determine the significance of SCU histology in patients with unresectable HB...
  2. ncbi Chemotherapeutic approaches for newly diagnosed hepatoblastoma: past, present, and future strategies
    Angela D Trobaugh-Lotrario
    Department of Pediatric Hematology Oncology, Sacred Heart Children s Hospital, Spokane, Washington 99204, USA
    Pediatr Blood Cancer 59:809-12. 2012
    ..A better understanding of the biologic and pathologic factors is critical for predicting tumor behavior and developing more logical risk-based treatments...
  3. ncbi Relapsed hepatoblastoma
    Angela D Trobaugh-Lotrario
    Department of Pediatric Hematology Oncology, Sacred Heart Children s Hospital, Spokane, Washington 99204, USA
    Pediatr Blood Cancer 59:813-7. 2012
    ..Advances in therapy for relapsed patients require concentrating enrollment in one or two phase I/II trials utilizing agents with promising preclinical data...
  4. ncbi Rhabdoid tumors of the liver: rare, aggressive, and poorly responsive to standard cytotoxic chemotherapy
    Angela D Trobaugh-Lotrario
    Sacred Heart Children s Hospital, Spokane, WA, USA
    Pediatr Blood Cancer 57:423-8. 2011
    ..Rhabdoid tumors of the liver are rare tumors that are difficult to cure. We compiled all the cases previously reported in the literature to review clinical data, treatments, and outcomes...